- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$157.98 MnMarket Estimate, 2026
$164.30 MnMarket Forecast, 2034
$224.86 MnCAGR, 2026–2034
4%Executive Summary: Middle East and Africa Sugar-based Excipients Market
- Market Scope: Comprehensive regional analysis of the Middle East and Africa (MEA) sugar-based excipients sector, detailing excipient types, functional uses, drug formulations, regulatory landscapes, and country-level profiles.
- Market Valuation: Valued at USD 157.98 million in 2025, reaching USD 164.30 million in 2026, and projected to expand to USD 224.86 million by 2034, growing at a steady CAGR of 4.00% from 2026 to 2034.
- Primary Growth Drivers: Rapid expansion of the generic drugs market, rising adoption of co-processed excipients, advancements in orally disintegrating tablets (ODTs), and increasing incorporation of patient-friendly flavoring and mannitol agents.
Key Market Segment Metrics
| Category | Leading Segment (Base Position) | Fastest-Growing / High-Growth Segment |
|---|---|---|
| By Type | Powders & Granules (accounted for the biggest share due to wide utilization across various drug formulations) | Syrups & Crystals (high-growth formats driven by liquid and specialized oral pediatric applications) |
| By Product | Actual Sugars (dominated the segment share as traditional stabilizing and taste-masking components) | Sugar Alcohols / Mannitol (fastest-growing segment driven by rising demand in specialized tablets) |
| By Functionality | Fillers & Diluents (held major market share due to widespread use in solid tablets and capsules) | Flavoring & Tonicity Agents (high-growth sectors improving patient palatability and drug absorption) |
| By Formulation | Oral Formulations (dominated the segment due to high consumption rates of oral medicines) | Parenteral & Topical Formulations (high-growth segments requiring high-purity complex excipients) |
| By Region | GCC (KSA & UAE) & South Africa (leading regional markets supported by advanced pharmaceutical manufacturing) | Israel, Egypt & Rest of MEA (fastest-growing sub-markets fueled by expanding healthcare investments) |
Major Market Players & Industry Landscape
Market Structure: Highly regulated and competitive landscape featuring major global specialty chemical and pharmaceutical excipient suppliers navigating strict FDA-approved facility constraints.
Key Companies: Archer Daniels Midland Company, The Lubrizol Corporation, Ashland Inc., Roquette Group, Associated British Foods Plc, Meggle AG, BASF SE, FMC Corporation, Cargill Inc., DFE Pharma, and Colorcon Inc.
Download Free Sample Report
Middle East and Africa Sugar-based Excipients Market Size
The Middle East and Africa Sugar-based Excipients Market size was calculated to be USD 157.98 million in 2025 and is anticipated to be worth USD 224.86 million by 2034, from USD 164.30 million in 2026, growing at a CAGR of 4% during the forecast period.
An excipient is a pharmacologically inactive element that is added along with the API in a particular formulation. It is added so as to provide stability, increase the absorption of the drug and to better other pharmacokinetic properties. There are many excipients available in the market, like gelatin, complex sugars, and various polymers. Sugar-based excipients are the most common of all, and are widely used in parenteral medicines. These excipients try to mask the bitterness of the pharmaceutical drug.
Market Drivers
The rapidly growing generic drugs market contributes heavily to the excipient market. There has been an increased usage in co-processed excipient and rising improvement of orally disintegrating tablets. These two factors also drive the market.The use of mannitol is also boosting the market. Drug manufacturers are trying to incorporate excipients in the formulations so that they can be easily taken by children and other patients.
Market Restraints
However, there is a shortage of FDA-approved manufacturing sites because of their strict regulations, making this a major restraint to market growth.
Segmental Analysis
Middle East and Africa sugar excipients market is segmented based on type, product, functionality, and formulation. Based on type, the market is segmented into Powder and granules, Crystal, Syrup, and others. Powders and granules accounted for the biggest share in the segment due to their wide use in various formulations. Based on product, the market is segmented into actual sugars, sugar alcohols, and artificial sweeteners. Actual sugar dominated the segment, whereas sugar alcohols are expected to witness fast growth over the forecast period due to a rise in the use of mannitol. On the basis of functionality, the market is segmented into fillers, diluents, flavouring agents, and tonicity agents. Fillers and diluents account for the major market share due to their widespread use in tablets and capsules. Based on formulation, the market is segmented into oral, topical, and parenteral. Oral formulations dominate this segment due to an increased use of various oral formulations.
Regional Analysis
Geographically, the Middle East and Africa Sugar-Based Excipients Market is segmented into KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, and the Rest of MEA. The market size of this region is small compared to other regions.
Key Players in the Market
Major Key Players in the MEA Sugar-Based Excipients Market are Archer Daniels Midland Company, The Lubrizol Corporation, Ashland Inc., Roquette Group, Associated British Foods Plc, Meggle AG, Basf SE, FMC Corporation, Cargill, Inc., Dfe Pharma, and Colorcon Inc